Am J Physiol Lung C:组织胺和白介素-4在气道上皮中通过EMEM16A的协同黏液分泌

2017-06-20 AlexYang MedSci原创

组织胺是一种重要的过敏反应调控子,并且黏液分泌过多是一种主要的过敏症状。然而,组织胺对气道粘膜上皮的黏液分泌的直接影响并没有很好的阐释。TMEM16A是一种Ca2+激活的氯离子通道,并且它与气道粘膜上皮的液体分泌密切相关。最近,有研究人员调查了是否组织胺直接从上皮细胞或者粘膜下腺体(SMG)诱导液体分泌,以及过敏气道疾病相关的机制。在来自鼻子或者器官的猪气道组织中,组织胺是一种强有力的促分泌素,并

组织胺是一种重要的过敏反应调控子,并且黏液分泌过多是一种主要的过敏症状。然而,组织胺对气道粘膜上皮的黏液分泌的直接影响并没有很好的阐释。TMEM16A是一种Ca2+激活的氯离子通道,并且它与气道粘膜上皮的液体分泌密切相关。

最近,有研究人员调查了是否组织胺直接从上皮细胞或者粘膜下腺体(SMG)诱导液体分泌,以及过敏气道疾病相关的机制。在来自鼻子或者器官的猪气道组织中,组织胺是一种强有力的促分泌素,并且可以直接诱导强烈的反应。然而,来自人类鼻腔组织的腺体分泌并没有被组织胺诱导,甚至是在过敏性鼻炎病人中。另外,H1R和H2R在SMG中,通过原位杂交技术并不明显。通过扩散池法,研究人员利用人工培养的人类鼻上皮(NHE)细胞用来测量短路电流的变化。研究发现,在正常条件下,组织胺诱导了阴离子分泌物的轻微的响应。这种响应可以由IL-4的刺激通过TMEM16A增强。另外,TMEM16A也许过敏性鼻炎的分泌物过多相关。IL-4的预处理可以增强组织胺响应,但可以通过一个TMEM16A抑制子抑制。研究还发现,在HNE细胞中,IL-4的24小时处理可以增强TMEM16A的表达。并且,与对照组相比,TMEM16A的表达在过敏性鼻炎组中显著的提高。最后,研究人员指出,该研究阐释了在人类气道表皮的组织胺诱导的液体分泌。另外,研究人员还观察到了腺体对组织胺分泌的物种间的差异。

原始出处:

Kang JW, Lee YH, Kang MJ et al. Synergistic mucus secretion by histamine and IL-4 through TMEM16A in airway epithelium. Am J Physiol Lung Cell Mol Physiol. 25 May 2017.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1682315, encodeId=bf8b16823153b, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Sat Jul 22 08:27:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766642, encodeId=698f1e6664224, content=<a href='/topic/show?id=fa47e772510' target=_blank style='color:#2F92EE;'>#组织胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77725, encryptionId=fa47e772510, topicName=组织胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac737846766, createdName=ms6323715314570549, createdTime=Fri Aug 04 16:27:00 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788810, encodeId=ee5b1e8881012, content=<a href='/topic/show?id=866d1421e4c' target=_blank style='color:#2F92EE;'>#Physio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14217, encryptionId=866d1421e4c, topicName=Physio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Aug 07 09:27:00 CST 2017, time=2017-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=214487, encodeId=ab1021448eb0, content=赚积分!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Jun 23 22:29:30 CST 2017, time=2017-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1372102, encodeId=083913e2102c2, content=<a href='/topic/show?id=6ca1e1621c4' target=_blank style='color:#2F92EE;'>#白介素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71621, encryptionId=6ca1e1621c4, topicName=白介素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e95336, createdName=budeshao, createdTime=Thu Jun 22 12:27:00 CST 2017, time=2017-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213265, encodeId=990e213265da, content=学习了涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jun 20 23:20:49 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213230, encodeId=740c213230b0, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Jun 20 21:35:24 CST 2017, time=2017-06-20, status=1, ipAttribution=)]
    2017-07-22 gwc392
  2. [GetPortalCommentsPageByObjectIdResponse(id=1682315, encodeId=bf8b16823153b, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Sat Jul 22 08:27:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766642, encodeId=698f1e6664224, content=<a href='/topic/show?id=fa47e772510' target=_blank style='color:#2F92EE;'>#组织胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77725, encryptionId=fa47e772510, topicName=组织胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac737846766, createdName=ms6323715314570549, createdTime=Fri Aug 04 16:27:00 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788810, encodeId=ee5b1e8881012, content=<a href='/topic/show?id=866d1421e4c' target=_blank style='color:#2F92EE;'>#Physio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14217, encryptionId=866d1421e4c, topicName=Physio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Aug 07 09:27:00 CST 2017, time=2017-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=214487, encodeId=ab1021448eb0, content=赚积分!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Jun 23 22:29:30 CST 2017, time=2017-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1372102, encodeId=083913e2102c2, content=<a href='/topic/show?id=6ca1e1621c4' target=_blank style='color:#2F92EE;'>#白介素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71621, encryptionId=6ca1e1621c4, topicName=白介素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e95336, createdName=budeshao, createdTime=Thu Jun 22 12:27:00 CST 2017, time=2017-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213265, encodeId=990e213265da, content=学习了涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jun 20 23:20:49 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213230, encodeId=740c213230b0, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Jun 20 21:35:24 CST 2017, time=2017-06-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1682315, encodeId=bf8b16823153b, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Sat Jul 22 08:27:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766642, encodeId=698f1e6664224, content=<a href='/topic/show?id=fa47e772510' target=_blank style='color:#2F92EE;'>#组织胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77725, encryptionId=fa47e772510, topicName=组织胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac737846766, createdName=ms6323715314570549, createdTime=Fri Aug 04 16:27:00 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788810, encodeId=ee5b1e8881012, content=<a href='/topic/show?id=866d1421e4c' target=_blank style='color:#2F92EE;'>#Physio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14217, encryptionId=866d1421e4c, topicName=Physio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Aug 07 09:27:00 CST 2017, time=2017-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=214487, encodeId=ab1021448eb0, content=赚积分!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Jun 23 22:29:30 CST 2017, time=2017-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1372102, encodeId=083913e2102c2, content=<a href='/topic/show?id=6ca1e1621c4' target=_blank style='color:#2F92EE;'>#白介素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71621, encryptionId=6ca1e1621c4, topicName=白介素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e95336, createdName=budeshao, createdTime=Thu Jun 22 12:27:00 CST 2017, time=2017-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213265, encodeId=990e213265da, content=学习了涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jun 20 23:20:49 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213230, encodeId=740c213230b0, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Jun 20 21:35:24 CST 2017, time=2017-06-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1682315, encodeId=bf8b16823153b, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Sat Jul 22 08:27:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766642, encodeId=698f1e6664224, content=<a href='/topic/show?id=fa47e772510' target=_blank style='color:#2F92EE;'>#组织胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77725, encryptionId=fa47e772510, topicName=组织胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac737846766, createdName=ms6323715314570549, createdTime=Fri Aug 04 16:27:00 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788810, encodeId=ee5b1e8881012, content=<a href='/topic/show?id=866d1421e4c' target=_blank style='color:#2F92EE;'>#Physio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14217, encryptionId=866d1421e4c, topicName=Physio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Aug 07 09:27:00 CST 2017, time=2017-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=214487, encodeId=ab1021448eb0, content=赚积分!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Jun 23 22:29:30 CST 2017, time=2017-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1372102, encodeId=083913e2102c2, content=<a href='/topic/show?id=6ca1e1621c4' target=_blank style='color:#2F92EE;'>#白介素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71621, encryptionId=6ca1e1621c4, topicName=白介素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e95336, createdName=budeshao, createdTime=Thu Jun 22 12:27:00 CST 2017, time=2017-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213265, encodeId=990e213265da, content=学习了涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jun 20 23:20:49 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213230, encodeId=740c213230b0, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Jun 20 21:35:24 CST 2017, time=2017-06-20, status=1, ipAttribution=)]
    2017-06-23 wei834766788

    赚积分!!!!!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1682315, encodeId=bf8b16823153b, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Sat Jul 22 08:27:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766642, encodeId=698f1e6664224, content=<a href='/topic/show?id=fa47e772510' target=_blank style='color:#2F92EE;'>#组织胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77725, encryptionId=fa47e772510, topicName=组织胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac737846766, createdName=ms6323715314570549, createdTime=Fri Aug 04 16:27:00 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788810, encodeId=ee5b1e8881012, content=<a href='/topic/show?id=866d1421e4c' target=_blank style='color:#2F92EE;'>#Physio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14217, encryptionId=866d1421e4c, topicName=Physio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Aug 07 09:27:00 CST 2017, time=2017-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=214487, encodeId=ab1021448eb0, content=赚积分!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Jun 23 22:29:30 CST 2017, time=2017-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1372102, encodeId=083913e2102c2, content=<a href='/topic/show?id=6ca1e1621c4' target=_blank style='color:#2F92EE;'>#白介素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71621, encryptionId=6ca1e1621c4, topicName=白介素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e95336, createdName=budeshao, createdTime=Thu Jun 22 12:27:00 CST 2017, time=2017-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213265, encodeId=990e213265da, content=学习了涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jun 20 23:20:49 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213230, encodeId=740c213230b0, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Jun 20 21:35:24 CST 2017, time=2017-06-20, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1682315, encodeId=bf8b16823153b, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Sat Jul 22 08:27:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766642, encodeId=698f1e6664224, content=<a href='/topic/show?id=fa47e772510' target=_blank style='color:#2F92EE;'>#组织胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77725, encryptionId=fa47e772510, topicName=组织胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac737846766, createdName=ms6323715314570549, createdTime=Fri Aug 04 16:27:00 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788810, encodeId=ee5b1e8881012, content=<a href='/topic/show?id=866d1421e4c' target=_blank style='color:#2F92EE;'>#Physio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14217, encryptionId=866d1421e4c, topicName=Physio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Aug 07 09:27:00 CST 2017, time=2017-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=214487, encodeId=ab1021448eb0, content=赚积分!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Jun 23 22:29:30 CST 2017, time=2017-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1372102, encodeId=083913e2102c2, content=<a href='/topic/show?id=6ca1e1621c4' target=_blank style='color:#2F92EE;'>#白介素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71621, encryptionId=6ca1e1621c4, topicName=白介素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e95336, createdName=budeshao, createdTime=Thu Jun 22 12:27:00 CST 2017, time=2017-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213265, encodeId=990e213265da, content=学习了涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jun 20 23:20:49 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213230, encodeId=740c213230b0, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Jun 20 21:35:24 CST 2017, time=2017-06-20, status=1, ipAttribution=)]
    2017-06-20 1ddf0692m34(暂无匿称)

    学习了涨知识

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1682315, encodeId=bf8b16823153b, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Sat Jul 22 08:27:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766642, encodeId=698f1e6664224, content=<a href='/topic/show?id=fa47e772510' target=_blank style='color:#2F92EE;'>#组织胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77725, encryptionId=fa47e772510, topicName=组织胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac737846766, createdName=ms6323715314570549, createdTime=Fri Aug 04 16:27:00 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788810, encodeId=ee5b1e8881012, content=<a href='/topic/show?id=866d1421e4c' target=_blank style='color:#2F92EE;'>#Physio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14217, encryptionId=866d1421e4c, topicName=Physio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Aug 07 09:27:00 CST 2017, time=2017-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=214487, encodeId=ab1021448eb0, content=赚积分!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Jun 23 22:29:30 CST 2017, time=2017-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1372102, encodeId=083913e2102c2, content=<a href='/topic/show?id=6ca1e1621c4' target=_blank style='color:#2F92EE;'>#白介素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71621, encryptionId=6ca1e1621c4, topicName=白介素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e95336, createdName=budeshao, createdTime=Thu Jun 22 12:27:00 CST 2017, time=2017-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213265, encodeId=990e213265da, content=学习了涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jun 20 23:20:49 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213230, encodeId=740c213230b0, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Jun 20 21:35:24 CST 2017, time=2017-06-20, status=1, ipAttribution=)]
    2017-06-20 1e145228m78(暂无匿称)

    学习了,谢谢作者分享!

    0

相关资讯

Immun Inflamm Dis:木聚硫钠在实验性过敏性鼻炎中的光谱Th2中和作用和抗炎症作用

Th2细胞激素就像白介素-4、-5和-13,被认为是过敏性鼻炎(AR)和哮喘的免疫病理学的重要驱使因子。最近,有研究人员探索了一种半合成的类肝素大分子碳水化合物-木聚硫钠(PPS)体内结合Th2细胞激素和发挥生物学中和作用以及抗炎症作用的能力。研究人员利用表面等离子共振(SPR)来检测PPS结合重组的Th2的能力,并利用Th2依赖的细胞增殖分析实验评估了生物学Th2中和作用。另外,利用鉴定过的AR

Sleep Breath:CPAP在阻塞性呼吸暂停病人中的影响:过敏性鼻炎与之相关么?

最近,有研究人员比较了睡眠窒息症病人中,持续气道正压通气(CPAP)对患有或者不患有过敏性鼻炎(AR/non AR)病人的影响。研究人员设计了一个预期的和纵向的研究。研究包括了34名持续性CPAB治疗的OSA病人,并且他们中17名有过敏性鼻炎,17名不患有过敏性鼻炎。在治疗前和治疗后2个月,研究人员评估了他们的临床参数(耳鼻喉症状、日间嗜睡度、总的鼻炎相关生活品质)、解剖学参数(耳鼻喉检查)、功能

Eur Arch Otorhinol:黏附分子和炎症细胞因子的表达对PM2.5的量为浓度依赖的

过敏性鼻炎(AR)代表了一种临床健康问题,大约影响了全世界5亿人口。最近,有研究人员探索了空气细颗粒物质(PM2.5)对患有过敏性鼻炎小鼠鼻粘膜的影响。研究包括了75只健康的雄性SD小鼠,并随机分为普通、模型、低浓度、中等浓度和高浓度组(每组15只小鼠)。AR小鼠模型利用致敏混合物建立并且利用不同浓度的PM2.5进行刺激。研究人员对打喷嚏和挠鼻事件进行了观察,并利用自动化的血清分析仪定量了白细胞数

Eur Arch Otorhinolaryngol:槲皮素在实验过敏性鼻炎小鼠模型中的作用

最近,有研究人员调查了槲皮素在实验过敏性鼻炎小鼠模型中是否具有治疗作用进行了研究。该研究包括了35只小鼠,并且被随机分成了四组:组1(n=5),假手术组;组2(n=10),槲皮素组,并接受80mg/kg每天的槲皮素量;组3(类固醇组,n=10),接受类固醇(糠酸莫米松);组4为对照组(n=10),只接受卵清蛋白。研究人员通过每天交替的腹腔注射的方法将小鼠利用卵清蛋白敏感化。在第15天,除了腹腔注射

Sci Rep:舌下腺尘螨免疫疗法在过敏性鼻炎的气道过敏原挑战中对循环红细胞的减少并没有影响

屋尘螨(HDM)过敏在欧洲是一种四季过敏性鼻炎(AR)的主要起因。之前,有研究人员报道了在一个哮喘小鼠模型中和草花粉敏感的AR病人中,循环红细胞数目的减少。最近,研究人员评估了在HDM敏感AR病人中的这些发现,并且评估了先前过敏免疫疗法的影响。先前在维也纳挑战室(VCC)的一个随机的、单中心的舌下免疫疗法(SLIT)试验中征集的77名HDM过敏性鼻炎病人(年龄在26.8±7.3岁;54.5%为女性

Clin Otolaryngol:过敏性鼻炎,而不是哮喘是龋齿的一个风险因子

哮喘(AS)与龋齿的相互关系是具有争议的,然而过敏性鼻炎(AR)与龋齿的关系仍旧还未建立。最近,有研究人员证实了AR、AS和龋齿之间的关系。该研究是一个回顾性的群体研究。数据是来自于台湾地区医疗保险数据库。参与者包括9380名出生在2004年的儿童,并对他们的从出生到9岁的数据进行了评估。研究人员对最初牙齿阶段(1-5岁)的龋齿临床访问频率和替牙阶段(6-9岁)的临床访问频率进行了计算。并对龋齿临